Vijay K Lathi's Net Worth
Estimate Recalculated Dec 3, 2025 08:04PM EST
Who is Vijay K Lathi
Vijay K Lathi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SGX PHARMACEUTICALS, INC., Relypsa Inc, iRhythm Technologies, Inc., CONCERT PHARMACEUTICALS, INC., Iterum Therapeutics plc, MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, ICAGEN INC, Harpoon Therapeutics, Inc., WORLD HEART CORP, and Oxford Immunotec Global PLC.
SEC CIK
Vijay K Lathi's CIK is 0001340806
Past Insider Trading and Trends
2017 was Vijay K Lathi's most active year for acquiring shares with 2 total transactions. Vijay K Lathi's most active month to acquire stocks was the month of March. 2006 saw Vijay K Lathi paying a total of $0.00 for 12,500 shares, this is the most they've acquired in one year.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
